Lobaplatin-Induced Apoptosis Requires p53-Mediated p38MAPK Activation Through ROS Generation in Non-Small-Cell Lung Cancer
出版年份 2019 全文链接
标题
Lobaplatin-Induced Apoptosis Requires p53-Mediated p38MAPK Activation Through ROS Generation in Non-Small-Cell Lung Cancer
作者
关键词
-
出版物
Frontiers in Oncology
Volume 9, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2019-07-24
DOI
10.3389/fonc.2019.00538
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Cancer statistics for African Americans, 2019
- (2019) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Comparison of Stable and Unstable Ethiodized Oil Emulsions for Transarterial Chemoembolization of Hepatocellular Carcinoma: Results of a Single-Center Double-Blind Prospective Randomized Controlled Trial
- (2018) Min-Ke He et al. JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY
- CQ sensitizes human pancreatic cancer cells to gemcitabine through the lysosomal apoptotic pathway via reactive oxygen species
- (2018) Zhiping Fu et al. Molecular Oncology
- Carotenoid Lutein Selectively Inhibits Breast Cancer Cell Growth and Potentiates the Effect of Chemotherapeutic Agents through ROS-Mediated Mechanisms
- (2018) Xiaoming Gong et al. MOLECULES
- Gallic acid sensitizes paclitaxel-resistant human ovarian carcinoma cells through an increase in reactive oxygen species and subsequent downregulation of ERK activation
- (2018) Jessica S�nchez-Carranza et al. ONCOLOGY REPORTS
- Prazosin but Not Tamsulosin Sensitises PC-3 and LNCaP Prostate Cancer Cells to Docetaxel
- (2018) Briohny H. Spencer et al. PHARMACOLOGY
- The Efficacy and Toxicity of Lobaplatin-contained Chemotherapy in Extensive-stage Small-cell Lung Cancer
- (2018) Ning-ning Zhou et al. Journal of Cancer
- Cisplatin and Pemetrexed Activate AXL and AXL Inhibitor BGB324 Enhances Mesothelioma Cell Death from Chemotherapy
- (2018) Derek B. Oien et al. Frontiers in Pharmacology
- Identification of Amentoflavone as a potent highly selective PARP-1 inhibitor and its potentiation on carboplatin in human Non-Small Cell Lung Cancer
- (2018) Xiao-Long Hu et al. PHYTOMEDICINE
- Lobaplatin induces BGC-823 human gastric carcinoma cell apoptosis via ROS- mitochondrial apoptotic pathway and impairs cell migration and invasion
- (2016) Yali Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Sulforaphene–Carboplatin Combination Synergistically Enhances Apoptosis by Disruption of Mitochondrial Membrane Potential and Cell Cycle Arrest in Human Non-Small Cell Lung Carcinoma
- (2016) Saswata Chatterjee et al. JOURNAL OF MEDICINAL FOOD
- Lobaplatin for the treatment of SK-MES-1 lung squamous cell line in vitro and in vivo
- (2016) Baoan Chen et al. OncoTargets and Therapy
- Lobaplatin arrests cell cycle progression, induces apoptosis and impairs migration and invasion in B16-F10 melanoma cell line in vitro
- (2015) Fangfang Yang et al. BIOMEDICINE & PHARMACOTHERAPY
- Gefitinib-mediated Reactive Oxygen Specie (ROS) Instigates Mitochondrial Dysfunction and Drug Resistance in Lung Cancer Cells
- (2015) Imoh S. Okon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Role of Reactive Oxygen Species in the Abrogation of Oxaliplatin Activity by Cetuximab in Colorectal Cancer
- (2015) Valeria Santoro et al. JNCI-Journal of the National Cancer Institute
- Role of Reactive Oxygen Species in the Abrogation of Oxaliplatin Activity by Cetuximab in Colorectal Cancer
- (2015) Valeria Santoro et al. JNCI-Journal of the National Cancer Institute
- Cisplatin Induces Cytotoxicity through the Mitogen-Activated Protein Kinase Pathways ana Activating Transcription Factor 3
- (2015) Carly St. Germain et al. NEOPLASIA
- Lobaplatin-TACE Combined with Radioactive125I Seed Implantation for Treatment of Primary Hepatocellular Carcinoma
- (2014) Sheng Peng et al. Asian Pacific Journal of Cancer Prevention
- Cisplatin in cancer therapy: Molecular mechanisms of action
- (2014) Shaloam Dasari et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Patterns in lung cancer incidence rates and trends by histologic type in the United States, 2004–2009
- (2014) Keisha A. Houston et al. LUNG CANCER
- A dual-targeting, p53-independent, apoptosis-inducing platinum(ii) anticancer complex, [Pt(BDIQQ)]Cl
- (2014) Kogularamanan Suntharalingam et al. Metallomics
- Smoking, p53 Mutation, and Lung Cancer
- (2014) Don L. Gibbons et al. MOLECULAR CANCER RESEARCH
- Lobaplatin arrests cell cycle progression, induces apoptosis and alters the proteome in human cervical cancer cell Line CaSki
- (2013) Xiaoqin Li et al. BIOMEDICINE & PHARMACOTHERAPY
- Gambogic acid synergistically potentiates cisplatin-induced apoptosis in non-small-cell lung cancer through suppressing NF-κB and MAPK/HO-1 signalling
- (2013) L-H Wang et al. BRITISH JOURNAL OF CANCER
- Antitumor activity of lobaplatin alone or in combination with antitubulin agents in non-small-cell lung cancer
- (2012) Cheng-Ying Xie et al. ANTI-CANCER DRUGS
- Vinca alkaloids cause aberrant ROS-mediated JNK activation, Mcl-1 downregulation, DNA damage, mitochondrial dysfunction, and apoptosis in lung adenocarcinoma cells
- (2012) Wei-Hsin Chiu et al. BIOCHEMICAL PHARMACOLOGY
- Lobaplatin induces apoptosis and arrests cell cycle progression in human cholangiocarcinoma cell line RBE
- (2011) Zhaohai Wang et al. BIOMEDICINE & PHARMACOTHERAPY
- Hyperglycemia regulates MDR-1, drug accumulation and ROS levels causing increased toxicity of carboplatin and 5-fluorouracil in MCF-7 cells
- (2011) Vimal Pandey et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Lobaplatin arrests cell cycle progression in human hepatocellular carcinoma cells
- (2010) Qiong Wu et al. Journal of Hematology & Oncology
- Blinded by the Light: The Growing Complexity of p53
- (2009) Karen H. Vousden et al. CELL
- Theaflavins retard human breast cancer cell migration by inhibiting NF-κB via p53-ROS cross-talk
- (2009) Arghya Adhikary et al. FEBS LETTERS
- An epidermal growth factor inhibitor, Gefitinib, induces apoptosis through a p53-dependent upregulation of pro-apoptotic molecules and downregulation of anti-apoptotic molecules in human lung adenocarcinoma A549 cells
- (2008) Gee-Chen Chang et al. EUROPEAN JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started